SLC2A4 and diabetes mellitus: Their antidiabetic effect on streptozotocin-induced diabetes was assessed in rat model with emphasis on blood glucose regulation, insulin receptor expression, GLUT4 levels, PI3K/AKT signaling, PKC/MAPK activity, and inflammatory biomarkers.